Paul Haber

14.0k total citations · 2 hit papers
296 papers, 9.4k citations indexed

About

Paul Haber is a scholar working on Epidemiology, Pathology and Forensic Medicine and General Health Professions. According to data from OpenAlex, Paul Haber has authored 296 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Epidemiology, 57 papers in Pathology and Forensic Medicine and 49 papers in General Health Professions. Recurrent topics in Paul Haber's work include Substance Abuse Treatment and Outcomes (80 papers), Alcohol Consumption and Health Effects (57 papers) and Liver Disease Diagnosis and Treatment (52 papers). Paul Haber is often cited by papers focused on Substance Abuse Treatment and Outcomes (80 papers), Alcohol Consumption and Health Effects (57 papers) and Liver Disease Diagnosis and Treatment (52 papers). Paul Haber collaborates with scholars based in Australia, United States and United Kingdom. Paul Haber's co-authors include Geoffrey W. McCaughan, Jeremy S. Wilson, Romano C. Pirola, Minoti V. Apte, Mark A. Korsten, Kirsten C. Morley, Ian D. Norton, Katherine M. Conigrave, Tanya Applegate and Andrew Baillie and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Paul Haber

282 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture

1998 738 citations Paul Haber, Geoffrey W. McCaughan et al. profile →
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

2020 202 citations Adrian Dunlop, Paul Haber et al. profile →

Peers

Countries citing papers authored by Paul Haber

Since Specialization

Citations

This map shows the geographic impact of Paul Haber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Haber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Haber more than expected).

Fields of papers citing papers by Paul Haber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Haber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Haber. The network helps show where Paul Haber may publish in the future.

Co-authorship network of co-authors of Paul Haber

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Haber. A scholar is included among the top collaborators of Paul Haber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Haber. Paul Haber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of contextual socioeconomic and demographic characteristics of residents on COVID-19 outcomes during public health restrictions in Sydney, Australia 2025 ·Australian and New Zealand Journal of Public Health ·Maria Gabriela Uribe Guajardo, (unknown), (unknown), Hueiming Liu, (unknown), (unknown), Ferdinand C. Mukumbang, (unknown), Michelle Cunich, Ilan Katz, Andrew Page, (unknown), James Gillespie, Paul Haber, Andrew Wilson, Leena Gupta, John Eastwood, Carmen Huckel Schneider	2
2	Neural cue reactivity and intrinsic functional connectivity in individuals with alcohol use disorder following treatment with topiramate or naltrexone 2025 ·Psychopharmacology ·Warren Logge, Paul Haber, (unknown), H. Colin Gallagher, Henry R. Kranzler, Kirsten C. Morley	0
3	Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings 2025 ·Drug and Alcohol Review ·Bethany White, (unknown), Paul Haber, (unknown), (unknown), Nicholas Lintzeris, Adrian Dunlop	1
4	Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with alcohol use disorder and liver disease at a liver transplant center 2025 ·Alcohol Clinical and Experimental Research ·J. J. van der Watt, Kirsten C. Morley, Paul Haber, Devanshi Seth, (unknown)	1
5	FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens 2025 ·Neuropsychopharmacology ·(unknown), (unknown), Eun A Choi, (unknown), (unknown), Andrew J. Lawrence, Paul Haber, Gavan P. McNally, (unknown)	0
6	The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial 2024 ·Contemporary Clinical Trials Communications ·(unknown), Warren Logge, (unknown), Marilena M. DeMayo, Anastasia Suraev, Iain S. McGregor, Paul Haber, Kirsten C. Morley	3
7	Low Risk of Cardiac Complications During Long-Term Follow-Up of Opioid Dependence 2024 ·Journal of Addiction Medicine ·(unknown), (unknown), Christina Marel, Katherine L. Mills, (unknown), (unknown), Tim Slade, Maree Teesson, Paul Haber	0
8	Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances: a feasibility trial 2023 ·Frontiers in Psychiatry ·(unknown), Amanda Brown, Amanda Baker, Billie Bonevski, Paul Haber, Yvonne Bonomo, (unknown), John Attia, (unknown), Daniel Barker, Gillian S. Gould, Adrian Dunlop	1
9	Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder 2023 ·Neuropsychobiology ·Warren Logge, Kirsten C. Morley, Paul Haber, Andrew Baillie	3
10	The role of impulsivity in the relationship between affect and alcohol consumption in young adults 2023 ·Alcohol Clinical and Experimental Research ·(unknown), Warren Logge, Benjamin C. Riordan, Tamlin S. Conner, Victoria Manning, E. Zayra Millan, Gavan P. McNally, Paul Haber, Kirsten C. Morley	1
11	Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study 2023 ·International Journal of Drug Policy ·Jack Wilson, Katherine L. Mills, Matthew Sunderland, Tom P. Freeman, (unknown), (unknown), Maree Teesson, Paul Haber, Christina Marel	1
12	Community-based alcohol education intervention (THEATRE) study to reduce harmful effects of alcohol in rural Sri Lanka: design and adaptation of a mixed-methods stepped wedge cluster randomised control trial 2023 ·BMJ Open ·Melissa Pearson, Andrew Dawson, Jacques Raubenheimer, (unknown), Katherine M. Conigrave, (unknown), Thilini Rajapakse, (unknown), Sisira Siribaddana, (unknown), Flemming Konradsen, Stephen Jan, Angela Dawson, Nicholas A. Buckley, (unknown), (unknown), (unknown), Paul Haber, (unknown), (unknown), Nick Glozier	0
13	Central markers of neuroinflammation in alcohol use disorder: A meta‐analysis of neuroimaging, cerebral spinal fluid, and postmortem studies 2023 ·Alcohol Clinical and Experimental Research ·(unknown), (unknown), James H. Conigrave, (unknown), Julia Stevens, (unknown), (unknown), (unknown), Greg T. Sutherland, Paul Haber, Kirsten C. Morley	14
14	A pilot study of a text message and online brief contact intervention following self-harm or a suicide attempt: A mixed methods evaluation 2022 ·General Hospital Psychiatry ·(unknown), Fiona Shand, Kirsten C. Morley, (unknown), Richard C. Henshaw, Katherine Petrie, (unknown), (unknown), (unknown), Sandersan Onie, Michelle Torok, Sofian Berrouiguet, Philip J. Batterham, Gregory Carter, Paul Haber, Helen Christensen, Mark Larsen	5
15	Detection of Δ⁹ THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices 2019 ·Drug Testing and Analysis ·Thomas R. Arkell, Richard C. Kevin, Jordyn Stuart, Nicholas Lintzeris, Paul Haber, Johannes G. Ramaekers, Iain S. McGregor	32
16	Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence 2018 ·Drug and Alcohol Review ·Suzanne Nielsen, Nicholas Lintzeris, Bridin Murnion, Louisa Degenhardt, Raimondo Bruno, Paul Haber, Jennifer Johnson, Mark Hardy, (unknown), (unknown), Adrian Dunlop, Apo Demirkol, (unknown), Nghi Phung, (unknown), Briony Larance	5
17	A Mobile Text Message Intervention to Reduce Repeat Suicidal Episodes: Design and Development of Reconnecting After a Suicide Attempt (RAFT) 2017 ·JMIR Mental Health ·Mark Larsen, Fiona Shand, Kirsten C. Morley, Philip J. Batterham, Katherine Petrie, (unknown), Sofian Berrouiguet, Paul Haber, Gregory Carter, Helen Christensen	24
18	Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia 2016 ·Journal of Addiction Medicine ·(unknown), Maryam Alavi, Julie Bruneau, Michelle Micallef, (unknown), Sanjeev Sockalingam, Adrian Dunlop, (unknown), Carolyn Day, Carla Treloar, Nicky Bath, Paul Haber, Gregory J. Dore, Jason Grebely	8
19	Medicinal drug use and driving 2013 ·(unknown), R W Chapman, Raimondo Bruno, (unknown), Paul Haber, Nicholas Lintzeris	1
20	Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection 2009 ·Gastroenterology ·Gregory J. Dore, Margaret Hellard, Gail Matthews, Jason Grebely, Paul Haber, Kathy Petoumenos, Barbara Yeung, Philippa Marks, Ingrid van Beek, Geoffrey W. McCaughan, Peter A. White, Rosemary French, William D. Rawlinson, Andrew R. Lloyd, John Kaldor	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact